Inhibition of Rho-associated kinase signaling prevents breast cancer metastasis to human bone

Cancer Research

Volumn 69, Issue 22, 2009, Pages 8742-8751

  Liu, Sijin ^a   Goldstein, Robert H ^a,b   Scepansky, Ellen M ^a,c   Rosenblatt, Michael ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sackler School of Graduate Biomedical Sciences   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACTIN; MICRORNA; MYC PROTEIN; MYOSIN; RHO KINASE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; BONE NEOPLASMS; BREAST NEOPLASMS; CELL MOVEMENT; ENZYME INHIBITORS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MICE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO-ASSOCIATED KINASES; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 72249097073     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1541     Document Type: Article

References (50)

1. Lane J, Martin TA, Watkins G, et al. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol 2008;33:585-593
2. Bourguignon LY, Zhu H, Shao L, et al. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton 1999;43:269-287
3. Li B, Zhao WD, Tan ZM, et al. Involvement of Rho/ ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett 2006;580:4252-4260 (Pubitemid 44037578)
4. Yoshioka K, Foletta V, Bernard O, et al. A role for LIM kinase in cancer invasion. Proc Natl Acad Sci U S A 2003;100:7247-7252 (Pubitemid 36706424)
5. Wyckoff JB, Pinner SE, Gschmeissner S, et al. ROCKand myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol 2006;16:1515-1523 (Pubitemid 44142977)
6. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008;133:217-222
7. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-2261 (Pubitemid 43271657)
8. Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGFâ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008;13:272-286 (Pubitemid 351318375)
9. Ota A, Tagawa H, Karnan S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-32 amplification in malignant lymphoma. Cancer Res 2004;64:3087-3095 (Pubitemid 38581408)
10. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005;435:828-833
11. Kuperwasser C, Dessain S, Bierbaum BE, et al. A mouse model of human breast cancer metastasis to human bone. Cancer Res 2005;65:6130-6138 (Pubitemid 40994398)
12. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-549 (Pubitemid 36808649)
13. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007;2:329-333
14. Tay YM, Tam WL, Ang YS, et al. MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells 2008;26:17-29.
15. Fontana L, Fiori ME, Albini S, et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS ONE 2008;3:e2236.
16. Liu S, Suragani RN, Wang F, et al. The function of heme-regulated eIF2α kinase in murine iron homeostasis and macrophage maturation. J Clin Invest 2007;117: 3296-3305 (Pubitemid 350096986)
17. Paulson KE, Rieger-Christ K, McDevitt MA, et al. Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer. Cancer Res 2007; 67:6136-6145 (Pubitemid 47037494)
18. Liu S, Bhattacharya S, Han A, et al. Haem-regulated eIF2α kinase is necessary for adaptive gene expression in erythroid precursors under the stress of iron deficiency. Br J Haematol 2008;143:129-137
19. -/- mice. Haematologica 2008; 93:753-756
20. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003;4:446-456 (Pubitemid 36648590)
21. Li Y, Friedmann DR, Mhatre AN, et al. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function. Cell Motil Cytoskeleton 2008;65:393-405. (Pubitemid 351657154)
22. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997;389: 990-994 (Pubitemid 27485693)
23. Torka R, Thuma F, Herzog V, et al. ROCK signaling mediates the adoption of different modes of migration and invasion in human mammary epithelial tumor cells. Exp Cell Res 2006;312:3857-3871 (Pubitemid 44633886)
24. Harb N, Archer TK, Sato N. The Rho-Rock-myosin signaling axis determines cell-cell integrity of selfrenewing pluripotent stem cells. PLoS ONE 2008;3:e3001.
25. Berenjeno IM, Nunez F, Bustelo XR. Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases. Oncogene 2007;26:4295-4305 (Pubitemid 46975793)
26. Sahai E, Marshall CJ. Rho-GTPases and cancer. Nat Rev Cancer 2002;2:133-142
27. Mizukami Y, Fujiki K, Duerr EM, et al. Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ ROCK and c-Myc. J Biol Chem 2006;281:13957-13963 (Pubitemid 43848321)
28. Watnick RS, Cheng YN, Rangarajan A, et al. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 2003;3:219-231
29. Fernandez PC, Frank SR, Wang L, et al. Genomic targets of the human c-Myc protein. Genes Dev 2003;17: 1115-1129 (Pubitemid 36534986)
30. Li Z, Van Calcar S, Qu C, et al. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci U S A 2003;100:8164-8169 (Pubitemid 36842516)
31. Blancato J, Singh B, Liu A, et al. Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. Br J Cancer 2004; 90:1612-1619 (Pubitemid 38648247)
32. Planas-Silva MD, Bruggeman RD, Grenko RT, et al. Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer. Exp Mol Pathol 2007;82:85-90.
33. 1 human breast carcinomas. Breast Cancer Res Treat 1999;54:39-45.
34. Liao DJ, Dickson RB. c-Myc in breast cancer. Endocr Relat Cancer 2000;7:143-164
35. Butt AJ, Sergio CM, Inman CK, et al. The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome. Breast Cancer Res 2008;10:R28.
36. Inomata M, Tagawa H, Guo YM, et al. MicroRNA- 17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2009;113: 396-402.
37. Pickering MT, Stadler BM, Kowalik TF. miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 2009;28:140-145
38. Hazan RB, Phillips GR, Qiao RF, et al. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000;148:779-790
39. Itoh K, Yoshioka K, Akedo H, et al. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999;5:221-225 (Pubitemid 29068531)
40. Moreau JE, Anderson K, Mauney JR, et al. Tissueengineered bone serves as a target for metastasis of human breast cancer in a mouse model. Cancer Res 2007;67:10304-10308 (Pubitemid 350070804)
41. Tagawa H, Karube K, Tsuzuki S, et al. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci 2007;98:1482-1490 (Pubitemid 47241774)
42. + myeloid cells that promote metastasis. Cancer Cell 2008;13:23-35.
43. Olson MF. Applications for ROCK kinase inhibition. Curr Opin Cell Biol 2008;20:242-248
44. Olson MF, Sahai E. The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis 2009;26:273-287
45. Deming SL, Nass SJ, Dickson RB, et al. C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer 2000;83: 1688-1695
46. Schlotter CM, Vogt U, Bosse U, et al. C-myc, not HER- 2/neu, can predict recurrence and mortality of patients with node-negative breast cancer. Breast Cancer Res 2003;5:R30-6.
47. Naidu R, Wahab NA, Yadav M, et al. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction. Int J Mol Med 2002;9:189-196
48. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008;8:976-990
49. 1 cyclindependent kinases. Cell 1993;75:805-816
50. Ishizaki T, Uehata M, Tamechika I, et al. Pharmacological properties of Y-27632, a specific inhibitor of Rhoassociated kinases. Mol Pharmacol 2000;57:976-983